Hoskinson Derick C, Dubuc Adrian M, Mason-Suares Heather
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine, 65 Landsdowne Str., Cambridge, MA 02115 USA.
Department of Pathology, Harvard Medical School and Brigham and Women's Hospital, 75 Francis Str., Boston, MA 02115 USA.
Curr Opin Genet Dev. 2017 Feb;42:33-39. doi: 10.1016/j.gde.2017.01.001. Epub 2017 Jan 31.
Accurate and consistent variant classification is required for Precision Medicine. But clinical variant classification remains in its infancy. While recent guidelines put forth jointly by the American College of Medical Genetics and Genomics (ACMG) and Association of Molecular Pathology (AMP) for the classification of Mendelian variants has advanced the field, the degree of subjectivity allowed by these guidelines can still lead to inconsistent classification across clinical molecular genetic laboratories. In addition, there are currently no such guidelines for somatic cancer variants, only published institutional practices. Additional variant classification guidelines, including disease- or gene-specific criteria, along with inter-laboratory data sharing is critical for accurate and consistent variant interpretation.
精准医学需要准确且一致的变异分类。但临床变异分类仍处于起步阶段。虽然美国医学遗传学与基因组学学会(ACMG)和分子病理学协会(AMP)联合发布的关于孟德尔变异分类的最新指南推动了该领域的发展,但这些指南所允许的主观性程度仍可能导致临床分子遗传实验室之间的分类不一致。此外,目前尚无针对体细胞癌症变异的此类指南,仅有已发表的机构做法。包括疾病或基因特异性标准在内的额外变异分类指南,以及实验室间的数据共享对于准确且一致的变异解读至关重要。